Multimorbidity, Polypharmacy, Severe Hypoglycemia, and Glycemic Control in Patients Using Glucose-Lowering Drugs for Type 2 Diabetes: A Retrospective Cohort Study Using Health Insurance Claims in Japan

[21] Kojima T(2022)Prevalence of noncommunicable diseases in Japan using a newly developed administrative claims database covering young, middle-aged, and elderly people JMA J 5 938-S124

[22] Mizukami K(2020)Paradox of glycemic management: multimorbidity, glycemic control, and high-risk medication use among adults with diabetes BMJ Open Diabetes Res Care 8 6-323

[23] Tomita N(2017)Synopsis of the 2017 U.S. Department of Veterans Affairs/U.S. Department of Defense clinical practice guideline: management of type 2 diabetes mellitus Ann Intern Med 167 280-1095

[24] Huang ES(2012)Diabetes in older adults: a consensus report J Am Geriatr Soc 60 221-7

[25] Karter AJ(2018)Incidence rate and patient characteristics of severe hypoglycemia in treated type 2 diabetes mellitus patients in Japan: retrospective diagnosis procedure combination database analysis J Diabetes Investig 9 S111-12

[26] Danielson KK(2019)Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention Lancet Diabetes Endocrinol 7 255-1059

[27] Warton EM(2004)Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications Br J Clin Pharmacol 57 1087-e116

[28] Ahmed AT(2019)Treatment patterns, persistence and adherence rates in patients with type 2 diabetes mellitus in Japan: a claims-based cohort study BMJ Open 9 420-1444

[29] Zoungas S(2022)Retrospective nationwide study on the trends in first-line antidiabetic medication for patients with type 2 diabetes in Japan J Diabetes Investig 13 1-1629

[30] Patel A(2018)2019 Update to: management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetologia 2020 1-311

[21] Kojima T(2022)Prevalence of noncommunicable diseases in Japan using a newly developed administrative claims database covering young, middle-aged, and elderly people JMA J 5 938-S124

[22] Mizukami K(2020)Paradox of glycemic management: multimorbidity, glycemic control, and high-risk medication use among adults with diabetes BMJ Open Diabetes Res Care 8 6-323

[23] Tomita N(2017)Synopsis of the 2017 U.S. Department of Veterans Affairs/U.S. Department of Defense clinical practice guideline: management of type 2 diabetes mellitus Ann Intern Med 167 280-1095

[24] Huang ES(2012)Diabetes in older adults: a consensus report J Am Geriatr Soc 60 221-7

[25] Karter AJ(2018)Incidence rate and patient characteristics of severe hypoglycemia in treated type 2 diabetes mellitus patients in Japan: retrospective diagnosis procedure combination database analysis J Diabetes Investig 9 S111-12

[26] Danielson KK(2019)Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention Lancet Diabetes Endocrinol 7 255-1059

[27] Warton EM(2004)Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications Br J Clin Pharmacol 57 1087-e116

[28] Ahmed AT(2019)Treatment patterns, persistence and adherence rates in patients with type 2 diabetes mellitus in Japan: a claims-based cohort study BMJ Open 9 420-1444

[29] Zoungas S(2022)Retrospective nationwide study on the trends in first-line antidiabetic medication for patients with type 2 diabetes in Japan J Diabetes Investig 13 1-1629

[30] Patel A(2018)2019 Update to: management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetologia 2020 1-311